Carnegie Capital Asset Management LLC Has $390,000 Stock Holdings in MetLife, Inc. (NYSE:MET)

Carnegie Capital Asset Management LLC raised its stake in MetLife, Inc. (NYSE:METFree Report) by 4.5% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 5,905 shares of the financial services provider’s stock after buying an additional 253 shares during the quarter. Carnegie Capital Asset Management LLC’s holdings in MetLife were worth $390,000 at the end of the most recent reporting period.

Other hedge funds also recently modified their holdings of the company. International Assets Investment Management LLC increased its stake in shares of MetLife by 678.4% during the 4th quarter. International Assets Investment Management LLC now owns 287,311 shares of the financial services provider’s stock worth $19,000,000 after purchasing an additional 250,402 shares during the last quarter. AustralianSuper Pty Ltd increased its stake in shares of MetLife by 19.2% during the 4th quarter. AustralianSuper Pty Ltd now owns 1,824,596 shares of the financial services provider’s stock worth $120,661,000 after purchasing an additional 293,925 shares during the last quarter. Nordea Investment Management AB increased its stake in shares of MetLife by 9.9% during the 4th quarter. Nordea Investment Management AB now owns 2,664,012 shares of the financial services provider’s stock worth $176,304,000 after purchasing an additional 240,564 shares during the last quarter. Acadian Asset Management LLC grew its stake in MetLife by 50.0% in the 3rd quarter. Acadian Asset Management LLC now owns 8,856 shares of the financial services provider’s stock valued at $557,000 after buying an additional 2,952 shares during the last quarter. Finally, MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH grew its stake in MetLife by 13.1% in the 4th quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH now owns 742,302 shares of the financial services provider’s stock valued at $49,088,000 after buying an additional 86,091 shares during the last quarter. Institutional investors and hedge funds own 89.81% of the company’s stock.

MetLife Price Performance

NYSE:MET opened at $68.92 on Thursday. The company has a 50-day moving average of $70.98 and a 200-day moving average of $66.68. The company has a market capitalization of $49.83 billion, a price-to-earnings ratio of 37.66, a PEG ratio of 0.52 and a beta of 1.04. MetLife, Inc. has a 52 week low of $48.95 and a 52 week high of $74.68. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.16 and a current ratio of 0.16.

MetLife (NYSE:METGet Free Report) last announced its quarterly earnings results on Wednesday, January 31st. The financial services provider reported $1.93 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.95 by ($0.02). MetLife had a net margin of 2.36% and a return on equity of 19.48%. The firm had revenue of $18.72 billion for the quarter, compared to the consensus estimate of $18.07 billion. As a group, equities research analysts anticipate that MetLife, Inc. will post 8.71 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts recently issued reports on the stock. The Goldman Sachs Group upgraded shares of MetLife from a “neutral” rating to a “buy” rating and raised their target price for the company from $70.00 to $80.00 in a research note on Monday, January 8th. Keefe, Bruyette & Woods raised their target price on shares of MetLife from $82.00 to $87.00 and gave the company an “outperform” rating in a research note on Wednesday, April 10th. Morgan Stanley raised their target price on shares of MetLife from $80.00 to $82.00 and gave the company an “overweight” rating in a research note on Monday. Piper Sandler raised their target price on shares of MetLife from $74.00 to $85.00 and gave the company an “overweight” rating in a research note on Friday, April 5th. Finally, Wells Fargo & Company raised their target price on shares of MetLife from $83.00 to $86.00 and gave the company an “overweight” rating in a research note on Thursday, April 11th. Two analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. According to MarketBeat.com, MetLife currently has an average rating of “Moderate Buy” and an average target price of $79.23.

Check Out Our Latest Research Report on MET

Insider Activity at MetLife

In related news, insider Ramy Tadros sold 4,026 shares of MetLife stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total transaction of $289,469.40. Following the completion of the transaction, the insider now directly owns 146,981 shares of the company’s stock, valued at approximately $10,567,933.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, insider Ramy Tadros sold 4,026 shares of MetLife stock in a transaction dated Wednesday, March 13th. The shares were sold at an average price of $71.90, for a total transaction of $289,469.40. Following the completion of the transaction, the insider now directly owns 146,981 shares of the company’s stock, valued at approximately $10,567,933.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Bill Pappas sold 27,000 shares of MetLife stock in a transaction dated Monday, March 18th. The shares were sold at an average price of $72.27, for a total transaction of $1,951,290.00. Following the transaction, the executive vice president now directly owns 57,768 shares of the company’s stock, valued at $4,174,893.36. The disclosure for this sale can be found here. 0.32% of the stock is currently owned by insiders.

MetLife Company Profile

(Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Featured Stories

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.